Parallel Session F: Challenges and Development of Rare Disease Management and Policy
- Rare disease is not rare
- Importance of Patient Registry for clinical advancement
- Confession from the family with Rare disease
- Speak for us, a new value for public policy
- Improving the Diagnosis of Rare Genetic Diseases through CoGenesis: An Integrated Bioinformatics Platform
- R&D for new drugs
Brian CHUNG, Hong Kong Genome Institute
Edwin CHAN, The Chinese University of Hong Kong
Rebecca YUEN, Tuberous Sclerosis Complex Association of Hong Kong
Joephy W. Y. CHAN, Legislative Council
Allen YU, Aldrin YIM, Codex Genetics Limited
Ivan LEE, Lee’s Pharmaceutical (HK) Limited